ENDRA Life Sciences (NDRA) Assets Average (2017 - 2026)

ENDRA Life Sciences (NDRA) has reported Assets Average for 10 consecutive years, with $3.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Assets Average rose 94.52% year-over-year to $3.6 million; the TTM figure through Mar 2026 stood at $3.6 million (up 94.52% YoY), while the FY2025 annual figure was $2.2 million, down 39.56% from the prior year.
• Assets Average improved to $3.6 million in Q1 2026 per NDRA's latest filing, from $2.2 million in the prior quarter.
• Across five years, Assets Average topped out at $13.8 million in Q3 2022 and bottomed at $403892.0 in Q4 2024.
• Historically, Assets Average has averaged $6.6 million across 5 years, with a median of $7.2 million in 2023.
• Annual changes were most pronounced in 2024 — Assets Average tumbled 94.37% — and 2025, when it surged 437.91%.
• ENDRA Life Sciences' Assets Average stood at $10.8 million in 2022, then slumped by 33.58% to $7.2 million in 2023, then sank by 94.37% to $403892.0 in 2024, then soared by 437.91% to $2.2 million in 2025, then jumped by 67.82% to $3.6 million in 2026.
• Business Quant data shows NDRA's Assets Average at $3.6 million in Q1 2026, $2.2 million in Q4 2025, and $1.6 million in Q3 2025.